Thomson BJ - Search Results

1

Irving WL, Thomson BJ. Irving WL, et al. Among authors: thomson bj. Int J Exp Pathol. 2001 Feb;82(1):1. doi: 10.1046/j.1365-2613.2001.00187.x. Int J Exp Pathol. 2001. PMID: 11422536 Free PMC article. No abstract available.

2

Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity.

Curran R, Jameson CL, Craggs JK, Grabowska AM, Thomson BJ, Robins A, Irving WL, Ball JK. Curran R, et al. Among authors: thomson bj. J Gen Virol. 2002 Jan;83(Pt 1):11-23. doi: 10.1099/0022-1317-83-1-11. J Gen Virol. 2002. PMID: 11752696

3

TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity.

Irving WL, Ball JK, Berridge S, Curran R, Grabowska AM, Jameson CL, Neal KR, Ryder SD, Thomson BJ. Irving WL, et al. Among authors: thomson bj. J Infect Dis. 1999 Jul;180(1):27-34. doi: 10.1086/314825. J Infect Dis. 1999. PMID: 10353857

4

Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA.

Craggs JK, Ball JK, Thomson BJ, Irving WL, Grabowska AM. Craggs JK, et al. Among authors: thomson bj. J Virol Methods. 2001 May;94(1-2):111-20. doi: 10.1016/s0166-0934(01)00281-6. J Virol Methods. 2001. PMID: 11337045

5

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection.

Grabowska AM, Lechner F, Klenerman P, Tighe PJ, Ryder S, Ball JK, Thomson BJ, Irving WL, Robins RA. Grabowska AM, et al. Among authors: thomson bj. Eur J Immunol. 2001 Aug;31(8):2388-94. doi: 10.1002/1521-4141(200108)31:8<2388::aid-immu2388>3.0.co;2-l. Eur J Immunol. 2001. PMID: 11500822 Free article.

6

Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.

Irving WL, Smith S, Cater R, Pugh S, Neal KR, Coupland CA, Ryder SD, Thomson BJ, Pringle M, Bicknell M, Hippisley-Cox J. Irving WL, et al. Among authors: thomson bj. J Viral Hepat. 2006 Apr;13(4):264-71. doi: 10.1111/j.1365-2893.2005.00698.x. J Viral Hepat. 2006. PMID: 16611193

7

Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.

Thomson BJ, Kwong G, Ratib S, Sweeting M, Ryder SD, De Angelis D, Grieve R, Irving WL; Trent HCV Study Group. Thomson BJ, et al. J Viral Hepat. 2008 Apr;15(4):271-8. doi: 10.1111/j.1365-2893.2007.00941.x. Epub 2007 Dec 11. J Viral Hepat. 2008. PMID: 18086181

8

Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.

Neal KR; Trent Hepatitis C Study Group; Ramsay S, Thomson BJ, Irving WL. Neal KR, et al. Among authors: thomson bj. Gut. 2007 Aug;56(8):1098-104. doi: 10.1136/gut.2006.113217. Epub 2007 Mar 7. Gut. 2007. PMID: 17344277 Free PMC article.

9

Serum autoantibody measurement for the detection of hepatocellular carcinoma.

Middleton CH, Irving W, Robertson JF, Murray A, Parsy-Kowalska CB, Macdonald IK, McElveen J, Allen J, Healey GF, Thomson BJ, Ryder SJ, Holdenrieder S, Chapman CJ. Middleton CH, et al. Among authors: thomson bj. PLoS One. 2014 Aug 5;9(8):e103867. doi: 10.1371/journal.pone.0103867. eCollection 2014. PLoS One. 2014. PMID: 25093332 Free PMC article.

10

Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?

Abo-Zeid Y, Urbanowicz RA, Thomson BJ, Irving WL, Tarr AW, Garnett MC. Abo-Zeid Y, et al. Among authors: thomson bj. Int J Pharm. 2018 Aug 25;547(1-2):572-581. doi: 10.1016/j.ijpharm.2018.06.027. Epub 2018 Jun 13. Int J Pharm. 2018. PMID: 29908332 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters